About this trial
Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and/or institutionalized patients?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Older than 18 years patient with type 1 or 2 diabetes
Treated with multiple insulin injections
Equipped with a continuous glucose measurement system and smart connected insulin pens at least one month before
Dependent on a health professional for treatment management.
Disqualifiers
None
Trial population
patient managed by a caregivers for the management of insulin therapy at home or in nursing home or in healthcare facility.
Trial design
Cohort
Prospective
Treatments tested in this trial
Counseling home caregivers
BehavioralAdvice on the proper use of insulin therapy will be given, if necessary, to caregivers. Patients are reviewed at 1 month of this first visit with a collection of the same data
Treatment groups
Trial outcomes
Primary outcomes
Insulin Injection
Percentage of insulin injections not as prescribed
Secondary outcomes
number of missed injections
Percentage of missed injections
number of injections
Percentage of injections performed with a dose deviation of +-20% from the prescribed dose
number of injections
Percentage of injections performed outside the meal time : more than 15 minutes before or more than an hour after the meal.
Continuous glucose measurement parameters
Time in range
Sponsors and contacts
Click on the lead sponsor to view all of their trials.